SCHEMBL30468535

SCHEMBL30468535

C[Si](C)(C)CCOCN1C(=O)C(Br)(Br)c2ccc(Cl)nc21

nearest known ligand 0.37

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21904287 1.00 DGAT1 (0.30) DGAT1
SCHEMBL21904551 0.82 DGAT1 (0.32) DGAT1
SCHEMBL21904555 0.81 CALCRL (0.31)
SCHEMBL259351 0.81 NPC1 (0.32) DGAT1
SCHEMBL29365567 0.81 NPC1 (0.32) DGAT1
SCHEMBL30976865 0.79
SCHEMBL21904458 0.78 USP1 (0.33) DGAT1
SCHEMBL30468499 0.78 USP1 (0.33) DGAT1
SCHEMBL30468538 0.75
SCHEMBL13735177 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024140679-A1 SPIROCYCLIC HPK1 ANTAGONISTS AND USES THEREOF INSILICO MEDICINE IP LIMITED (CN) 2024-07-04 WO disclosed
CN-110769821-B Spiro indolines as IL-17 modulators UCB生物制药有限责任公司 2023-07-07 CN disclosed